Living Donor vs Deceased Donor Kidney Transplant — Key Differences Every Patient Should Understand
If you or a family member has been told a kidney transplant is needed, one of the first questions is: where does the kidney come from? The answer shapes the entire transplant trajectory the waiting time, the quality of the kidney, the surgical planning, and ultimately the long-term outcome.
Kidney transplants in India come from two sources: living donors (a willing person, typically a family member or spouse, who donates one of their two functioning kidneys) and deceased donors (a brain-dead individual whose family has consented to organ donation, coordinated through NOTTO — the National Organ and Tissue Transplant Organisation).
Understanding the differences between these two pathways their outcomes, their logistics, their eligibility requirements, and their specific advantages and challenges is essential for making an informed decision and for planning the transplant timeline effectively. This post explains both pathways as they operate at KIMS Secunderabad, which has performed over 1,500 transplants including both living and deceased donor cases.
Living donor kidney transplant — the preferred pathway
A living donor kidney transplant is performed from a willing, medically suitable living person who donates one kidney. The living donor retains their second kidney, which compensates fully for the donated organ, leaving the donor with normal long-term kidney function. Living donor transplant is the preferred pathway wherever a suitable donor is available for several significant reasons:
Superior graft survival
Living donor kidneys have significantly better outcomes than deceased donor kidneys. Five-year graft survival exceeds 85–90% because the donor is thoroughly evaluated, the kidney is removed electively, and 'ischaemia time' (time without blood supply) is minimised to typically less than 1 hour.
Timing is controlled
The procedure is scheduled electively. There is no waiting list or middle-of-the-night emergency call. This planning advantage allows both the donor and recipient to be medically optimised before the surgery takes place.
Pre-emptive transplant is possible
Only with a living donor can a transplant be performed before dialysis ever starts (pre-emptive). When the recipient's eGFR falls below 15, this path provides the best possible long-term outcomes by avoiding the systemic burden of the dialysis period.
ABO-incompatible transplant
Historically, donors had to have compatible blood groups. At KIMS, the blood group barrier is removed using rituximab desensitisation and plasmapheresis. This expands the pool so any willing living donor can be evaluated regardless of blood group.
Who can be a living kidney donor?
Indian law (the Transplantation of Human Organs and Tissues Act, 1994 and its amendments) defines two categories of permitted living kidney donors:
Related Donors
Parents, siblings, children, grandparents, grandchildren, and spouses are permitted as related living donors. These constitute the majority of transplants in India.
Requirements: The donor must have one healthy kidney to donate, no conditions that increase donation risk, and be fully informed of the long-term health implications.
Unrelated (Emotionally Related)
Close friends or others with documented relationships are permitted with State Authorisation Committee (SAC) clearance. This involves formal interviews to confirm the donation is altruistic.
Paired Exchange: "Swap" transplants are also an option at KIMS for donor-recipient pairs who are blood-group incompatible with each other but match with another pair.
Living donor evaluation at KIMS covers: medical fitness (eGFR, 24-hour urine protein, blood pressure, kidney anatomy, absence of systemic disease), surgical fitness (cardiac assessment, anaesthetic clearance), immunological compatibility (ABO and HLA crossmatch), and psychosocial assessment confirming voluntary, informed decision-making. The evaluation typically takes 4 to 8 weeks.
Deceased donor kidney transplant — the NOTTO pathway
Deceased donor (cadaveric) transplant uses a kidney from a brain-dead person whose family has consented to organ donation. In India, this is coordinated by NOTTO at the national level and TSOTTO in Telangana. KIMS Secunderabad is registered for both retrieval and transplant.
Listing
Recipients are registered on the NOTTO waiting list after medical evaluation, HLA typing, and PRA measurement. Priority is determined by time on dialysis, sensitisation levels, blood group, and medical urgency.
Waiting time
Waiting times vary by state and blood group. Patients with Blood Group O or high sensitisation (PRA) typically wait longer. KIMS provide realistic expectations based on current regional availability data.
The call
When a match is found, KIMS contacts the recipient immediately (24/7). You must reach the hospital within 4 to 6 hours. Our surgical and preparation teams are mobilised simultaneously to ensure a rapid transition.
Expanded criteria donors (ECD)
KIMS considers kidneys from older donors or those with controlled hypertension. While graft survival may be modestly shorter, ECD kidneys provide a life-transforming alternative to years of continued dialysis.
Side-by-side comparison — Living vs Deceased Donor
| Factor | Living Donor | Deceased Donor (NOTTO) |
|---|---|---|
| Graft survival (5-year) | 85–90%+ — elective surgery, optimised donor, minimal ischaemia time. | 75–85% — variable by donor age, cause of death, and ischaemia time. |
| Waiting time | Months (donor evaluation 4–8 weeks + any desensitisation protocol). | Months to years on NOTTO waiting list — highly variable by blood group and sensitisation. |
| Timing | Fully planned, elective — optimal preparation for both parties. | Emergency call at any time — recipient must reach hospital within 4–6 hours. |
| Pre-emptive transplant | Possible — greatest timing advantage, best outcomes. | Not possible — timing cannot be predicted. |
| Blood group | Compatible OR ABO-incompatible protocol at KIMS. | ABO-compatible required (ABO-incompatible deceased donor uncommon). |
| Legal requirements | TOHO Act authorisation, ethics committee, SAC for unrelated donors. | NOTTO listing, state committee clearance, brain-death certification at donor hospital. |
| Donor health risk | Real but small — ~0.03% surgical mortality, slightly increased long-term CKD risk. | No living person at risk. |
| Cost | Generally lower — no waiting time costs, planned logistics. | May include transport, coordination, and emergency surgical team costs. |
| Aarogyasri | Yes — at KIMS. | Yes — at KIMS. |
The ABO-incompatible option — removing the blood group barrier
The most common reason families in India are told a living donor transplant is 'not possible' is blood group incompatibility. A parent who is blood group O cannot donate to a blood group A child under standard protocols. A blood group B spouse cannot donate to a blood group A recipient. ABO-incompatible kidney transplant at KIMS removes this barrier.
The protocol rituximab infusion to deplete antibody-producing B-cells, followed by 4 to 8 plasmapheresis sessions to reduce the blood group antibody titre to a safe threshold takes 4 to 6 weeks before transplant. Graft survival at experienced centres approaches compatible transplant outcomes. KIMS performs ABO-incompatible living donor transplants routinely. If a potential donor has been dismissed because of blood group mismatch, call KIMS for an ABO-incompatible evaluation before concluding that living donor transplant is impossible.
If your family has a willing living donor with any blood group, the first step is evaluation not assumption about compatibility. Blood group O recipient with a blood group A donor? Potentially ABO-incompatible transplant. Blood group B recipient with blood group O donor? Compatible no protocol needed. Blood group AB recipient? Universal recipient any donor is compatible. The KIMS transplant team maps out every option at the first evaluation consultation.
Frequently Asked Questions — Living vs Deceased Donor
In terms of graft survival, function, and recipient outcomes, yes — living donor kidneys consistently outperform deceased donor kidneys across every measurable metric. Five-year graft survival for living donor transplants exceeds 85 to 90%; for deceased donor transplants it is 75 to 85%. The superior outcomes result from the thorough evaluation of the living donor, the elective nature of the surgery, and the minimal ischaemia time (the kidney is functioning in the donor moments before being placed in the recipient). Where a suitable living donor is available, living donor transplant is preferred.
Yes — spouses are permitted living kidney donors in India under the Transplantation of Human Organs and Tissues Act. Spousal donation is among the most common living donor transplant situations. The evaluation confirms the spouse's medical fitness, the voluntary nature of the decision, and the blood group and HLA compatibility. If the blood groups are incompatible, ABO-incompatible transplant at KIMS removes this barrier. The ethics committee review process for spousal donation typically takes 2 to 4 weeks.
Living kidney donors lose approximately 50% of their total renal function at the time of donation. The remaining kidney compensates through hyperfiltration, and total kidney function recovers to approximately 70 to 75% of the pre-donation level within 3 to 6 months. Long-term studies consistently show that carefully evaluated living kidney donors have a life expectancy similar to matched non-donors. Donors are advised to maintain a healthy lifestyle, avoid NSAIDs, and have annual kidney function checks. The long-term risk of kidney failure in carefully selected living donors is small — approximately 0.3 to 0.5% over 15 years.
Registration on the deceased donor waiting list (NOTTO) is managed through the KIMS transplant team after the recipient has completed the transplant evaluation (medical fitness, HLA typing, PRA measurement, and ethics clearance). Once complete, the KIMS team submits the registration to TSOTTO (Telangana State Organ and Tissue Transplant Organisation). Priority is based on time on dialysis, blood group, degree of sensitisation, and medical urgency. Call 040 - 44885000 to begin.
Yes — a blood group O donor is the universal donor for transplant. In this direction (O to A), the transplant is compatible and no special desensitisation protocol is needed. However, if the direction was reversed (A donor to O recipient), it would be ABO-incompatible because the O recipient has anti-A antibodies. The KIMS transplant team maps specific compatibility for every donor-recipient pair and manages incompatible combinations with our desensitisation protocol.
Living kidney donation is safe but not risk-free. The surgical mortality risk is approximately 0.03% (3 in 10,000), comparable to other elective abdominal surgeries. The long-term risk of kidney failure is approximately 0.3 to 0.5% over 15 years, which is why rigorous pre-donation evaluation is essential. Donors at KIMS are informed of these risks honestly and the ethics committee ensures the decision is voluntary and well-understood.
KIMS Secunderabad — with 1,500+ kidney transplants, we offer living and deceased donor pathways, ABO-incompatible protocols, and swap (paired exchange) through the TSTA programme. We are NOTTO and TSOTTO registered and offer pre-emptive transplant for CKD Stage 4 patients. We are Aarogyasri, CGHS, and EHS empanelled, and were recognized as the 'Best Hospital of the Year in Nephrology' by Times Healthcare Achievers.